ABFERO PHARMACEUTICALS
Abfero Pharmaceuticals is a clinical-stage pharmaceutical company that specializes in the healthcare and medical industry. The company focuses exclusively on iron as a therapeutic target, its mission is to develop novel therapies for the treatment of iron-overload conditions. It was founded in 2016 and headquartered in Lexington, Massachusetts.
ABFERO PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2016-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.abferopharmaceuticals.com
Total Employee:
1+
Status:
Active
Total Funding:
6.68 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Founder
Investors List
DeepWork Capital
DeepWork Capital investment in Seed Round - Abfero Pharmaceuticals
DeepWork Capital
DeepWork Capital investment in Seed Round - Abfero Pharmaceuticals
Official Site Inspections
http://www.abferopharmaceuticals.com
- Host name: box2378.bluehost.com
- IP address: 50.87.170.207
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Abfero Pharmaceuticals"
Abfero Pharmaceuticals | Iron as a Therapeutic Target
Our mission. Abfero Pharmaceuticals Inc. is a clinical stage pharmaceutical company focused exclusively on iron as a therapeutic target. Our mission is to develop best-in-class oral iron …See details»
Abfero Pharmaceuticals - Crunchbase Company Profile …
Abfero Pharmaceuticals is a clinical-stage pharmaceutical company that specializes in the healthcare and medical industry. The company focuses …See details»
Abfero Pharmaceuticals, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Abfero Pharmaceuticals, Inc. of Boston, MA. Get the latest business insights from Dun & Bradstreet.See details»
AbFero Pharmaceuticals, Inc. | LinkedIn
AbFero Pharmaceuticals is a privately-held clinical stage pharmaceutical company dedicated to treating diseases of iron overload. Our therapeutic platform addresses transfusion-related iron ...See details»
Abfero Pharmaceuticals Company Profile | Management and
Www.abferopharmaceuticals.com . Abfero Pharmaceuticals Profile and History. AbFero Pharmaceuticals, Inc. is a privately-held clinical stage pharmaceutical company dedicated to …See details»
PHARMACOSMOS GROUP ACQUIRES BOSTON BASED CLINICAL …
Visit: https://www.abferopharmaceuticals.com. Pharmacosmos Contact Information Tobias S. Christensen, COO +45 5948 5959, [email protected]. Title: Press-Release …See details»
Pharmacosmos Group Acquires Boston Based Clinical Stage …
Nov 11, 2021 For more information, visit: https://www.abferopharmaceuticals.com. Pharmacosmos Contact Information Tobias S. Christensen, COO +45 5948 5959, [email …See details»
Abfero Pharmaceuticals - PitchBook
Www.abferopharmaceuticals.com. Ownership Status. Acquired/Merged (Operating Subsidiary) Financing Status. Formerly VC-backed. Corporate Office. 867 Boylston Street; Floor 5; …See details»
Contact - Abfero Pharmaceuticals
AbFero Pharmaceuticals has been acquired by Pharmacosmos. Pharmacosmos is specialized in iron metabolism. Our website is for general information purposes only.See details»
Abfero Pharmaceuticals - Craft
See insights on Abfero Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
AbFero Pharmaceuticals - Products, Competitors, Financials, …
Headquarters Location. 405 Waltham Street Suite 353. Lexington, Massachusetts, 02421, United States. 781-266-7297See details»
Overview, News & Similar companies - ZoomInfo.com
Feb 16, 2021 www.abferopharmaceuticals.com. Revenue <$5 Million. Industry Drug Stores & Pharmacies Retail . Recent News & Media. AbFero Pharmaceuticals Announces Initiation Of …See details»
Acquisition of UF Faculty Startup AbFero Provides Iron Chelators …
Nov 16, 2021 website builders Removing excess iron may provide therapeutic relief for macular degeneration, Parkinson’s, and more. Late last week, Danish biotech Pharmacosmos …See details»
News - Abfero Pharmaceuticals
Nov 11, 2021 Latest News from Abfero Pharmaceuticals. Boston, MA (May 20, 2021) – AbFero Pharmaceuticals, Inc., a privately-held clinical stage pharmaceutical company dedicated to …See details»
AbFero Pharmaceuticals Announces Funding From Cure …
HARWELL, England, Feb. 17, 2021 /PRNewswire/ -- AbFero Ltd., a subsidiary of AbFero Pharmaceuticals, Inc., a privately-held clinical stage pharmaceutical company dedicated to …See details»
AbFero to Receive € 2M Eurostars Funding for Parkinson's Disease ...
Dec 1, 2020 Clinical stage pharmaceutical company forms multi-national research consortium to establish iron chelating compounds as disease modifying therapy ...See details»
AbFero EUREKA Eurostars - abferopharmaceuticals.com
Www.abferopharmaceuticals.com. Investor & Media Contact: Mih-Ho Cha [email protected] . Title: AbFero EUREKA Eurostars Created Date: 11/30/2020 10:27:16 PM ...See details»
Pipeline - Abfero Pharmaceuticals
Our therapeutic platform addresses transfusional iron overload (TIO) and iron accumulation associated with diseases of aging. With SP-420’s ability to cross the blood-brain and blood …See details»
AbFero to Receive € 2M Eurostars Funding for Parkinson's Disease …
HARWELL, England, Dec. 1, 2020 /PRNewswire/ -- AbFero Ltd., a subsidiary of AbFero Pharmaceuticals, Inc., a privately-held clinical stage pharmaceutical company dedicated to …See details»
20210217 AbFero Cure Parkinson's Grant [Final]
Www.abferopharmaceuticals.com. Investor & Media Contact: Mih-Ho Cha [email protected]. Title: 20210217 AbFero Cure Parkinson's Grant [Final] Created Date:See details»